FutureMeds is a fast-growing independent European Site Management Organisation supporting pharmaceutical companies, Sponsors and CROs and contributing to research to find effective treatments and medications for all patients who need them. FutureMeds’ Dedicated Research Site teams strive to accelerate study timelines, streamline processes, lower costs and improve data quality to help accelerate drug development and patient access to new treatments. Through acquisitions and a strategic focus on patient experience, FutureMeds has developed large qualified patient pools across Europe that enables faster patient enrollment, strong retention and help generate more accurate results. FutureMeds has arisen from the leadership team’s passion for Clinical Research and their drive and many years of experience building Dedicated Research Site networks across the globe. Previously they created and scaled Synexus (now AES within PPD).